Entomophila Infection-Related Intracranial Infections

Xiaoyong Du,Shuang Ding,Jian Wang,Chunhui Jiang,Jun Li,Lei Wu,Hanqiu Liu,Weiwei Wang,Dan Zhang,Jun Lü
DOI: https://doi.org/10.1007/978-981-99-0039-8_8
2023-01-01
Abstract:Epidemic encephalitis B is an acute infectious disease of the central nervous system caused by the encephalitis B virus, which is neurotropic in nature, with inflammation of the brain parenchyma as the main change. The disease is also called Japanese encephalitis because it was the first successful isolation of B encephalitis virus in Japan. The virus is transmitted between animal and human hosts through mosquito vectors and is prevalent in summer and autumn, mostly affecting children. The virus multiplies in the mononuclear phagocyte system after being bitten by a virulent mosquito and then enters the bloodstream to form viremia. The onset and severity of the disease depends mainly on the number of viruses, their virulence, and the immunity of the infected individuals. In people with competent immunity, the infection is mostly latent, while in people with weak immunity, the encephalitis B virus destructs the blood-brain barrier and invades the central nervous system, causing encephalitis, which has a high mortality rate and is prone to sequelae. Most infected individuals do not develop the disease and are latent infected. Epidemic encephalitis B mainly affects children under the age of 10. It is more frequent in the population aged 2–6 and more often in male than in female. Epidemic encephalitis B can also occur in adults in non-endemic areas. Clinical symptoms such as acute fever, convulsions, impaired consciousness, meningeal irritation, and respiratory failure with sequelae may occur in severe cases [1].
What problem does this paper attempt to address?